TO THE EDITOR: I read ''Pharmacology, Part 3A''in the December 2018 issue of the Journal
of Nuclear Medicine Technology by Geoffrey M. Currie (1). I am concerned about one aspect …

PURPOSE: To establish normal gallbladder ejection fraction (GBEF) values for two sincalide
(cholecystokinin [CCK]) infusion dose rates, 0.01 μg per kilogram of body weight infused for …

Sincalide (Kinevac) is widely used in conjunction with cholescintigraphy for a variety of
clinical indications. Over the years, numerous publications have verified the optimal infusion …

In August 2001, Bracco Diagnostic, Inc.(Princeton, NJ), announced upcoming shortages of
Kinevac (sincalide for injection) as a result of delays in technology transfer and …

SNM Practice Guideline for Hepatobiliary Scintigraphy 4.0 (1), it was my privilege to
collaborate with a dedicated group of professionals who worked tirelessly on this update …

P1041 Introduction: Current protocol guidelines for sincalide-stimulated cholescintigraphy
(SSC) call for a 60-minute infusion of sincalide with planar imaging, with calculated 60 …

Sincalide-stimulated cholescintigraphy is performed to quantify gallbladder contraction and
emptying. However, different infusion methods are used for this study. Our purpose was to …

Patients on total parenteral nutrition or after prolonged fasting may require treatment with
cholecystokinin (CCK) prior to hepatobiliary imaging. Some may also require evaluation of …

Purpose Current guidelines for sincalide-stimulated cholescintigraphy (SSC) call for a 60-
minute sincalide infusion, and a gallbladder ejection fraction (GBEF)≥ 38% is considered …

Cholecystokinin (CCK) and its C-terminal octapeptide analog. Sincalide, have been utilized
in two separate roles for the evaluation of gallbladder disease. These are:(1) prior to …